Characterization of the Antiviral Effect of 2′,3′-Dideoxy-2′, 3′-Didehydro-β-l-5-Fluorocytidine in the Duck Hepatitis B Virus Infection Model

Benzer Materyaller

• Antiviral Activity of β-l-2′,3′-Dideoxy-2′,3′-Didehydro-5-Fluorocytidine in Woodchucks Chronically Infected with Woodchuck Hepatitis Virus
  Yazar:: Le Guerhier, F., ve diğerleri
  Baskı/Yayın Bilgisi: (2001)
• Pharmacokinetics of the Antiviral Agent β-d-2′,3′-Didehydro-2′,3′-Dideoxy-5-Fluorocytidine in Rhesus Monkeys
  Yazar:: Ma, Li, ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• Anti-Hepatitis B Virus Activity and Metabolism of 2′,3′-Dideoxy-2′,3′-Didehydro-β-l(−)-5-Fluorocytidine
  Yazar:: Zhu, Yong-Lian, ve diğerleri
  Baskı/Yayın Bilgisi: (1998)
• 2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
  Yazar:: Zoulim, F, ve diğerleri
  Baskı/Yayın Bilgisi: (1996)
• In Vitro Selection and Analysis of Human Immunodeficiency Virus Type 1 Resistant to Derivatives of β-2′,3′-Didehydro-2′,3′-Dideoxy-5-Fluorocytidine
  Yazar:: Hammond, Jennifer L., ve diğerleri
  Baskı/Yayın Bilgisi: (2005)